06.08.26 -- BIOSECURE Act And The 8 Supply-Chain Lessons Sponsors Can't Ignore

Assimilate how selecting the right solubility‑enhancing technology improves early exposure, supports flexible dosing, and lays a strong foundation for downstream oral drug development.

Platform biotech companies face critical choices on partnering, licensing, or selling technology—decisions that shape focus, valuation, and long‑term success beyond scientific innovation alone.

Discover how tailored strategies, advanced technologies, and scientifically driven decision frameworks are accelerating the successful development and regulatory readiness of next-generation ADCs.

Pharma is shifting to integrated manufacturing partners to handle complex drugs. Technical synergy and global alignment boost resilience and speed patient access.

See how controlled ice nucleation shortens lyophilization cycles, supports higher drying temperatures, and reduces complexity for amorphous and mixed formulations without sacrificing quality.

Uncover the growing demand for high‑concentration biologics, and the formulation, viscosity, and manufacturing challenges driving new technologies for stable, scalable drug development.

View how tunable expression technology achieves optimal chain pairing and high titers for complex biologics, from four-chain bispecifics to difficult-to-express proteins, using platform processes.

Leachables risk is a concern in biomanufacturing. Review practices for evaluating risks from polymeric single-use systems, including tools and insights to support robust assessments and compliance.

Read how lyophilization revolutionizes biologic drug manufacturing and ensures potent, stable treatments for complex diseases.

Begin your ADC manufacturing journey by finding a partner who can provide support through every phase of the conjugate life cycle, including process optimization, scale-up, and validation.

Effective drug substance handoff to fill-finish manufacturing depends on early collaboration, clear communication, and proactive planning to reduce risks, ensure quality, and maintain timelines.

By leveraging expertise across a global network and executing a streamlined, rapid technology transfer, we were able to enable a highly data-driven approach to clone selection and process optimization.

Development partnerships start with early alignment, transparency, and shared accountability, reducing risk, improving scalability, and supporting success as programs advance.